Accessory Mutations Maintain Stability in Drug-Resistant HIV-1 Protease
- 22 July 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 410 (4), 756-760
- https://doi.org/10.1016/j.jmb.2011.03.038
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Effect of Clade-Specific Sequence Polymorphisms on HIV-1 Protease Activity and Inhibitor Resistance PathwaysJournal of Virology, 2010
- Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir‐binding siteJBIC Journal of Biological Inorganic Chemistry, 2004
- HIV Drug ResistanceThe New England Journal of Medicine, 2004
- Is Resistance Futile?Current Drug Targets - Infectious Disorders, 2003
- Human immunodeficiency virus reverse transcriptase and protease sequence databaseNucleic Acids Research, 2003
- A Major Role for a Set of Non-Active Site Mutations in the Development of HIV-1 Protease Drug ResistanceBiochemistry, 2003
- Evolution of an Antibiotic Resistance Enzyme Constrained by Stability and Activity Trade-offsJournal of Molecular Biology, 2002
- Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapyAIDS, 1999
- Drug resistance mutations can affect dimer stability of HIV-1 protease at neutral pHProtein Science, 1999
- Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical TrialsOnline Journal of Public Health Informatics, 1996